The use of biosimilar medicines in oncology - position statement of the Brazilian Society of Clinical Oncology (SBOC)

Overview of attention for article published in Brazilian Journal of Medical and Biological Research, January 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (77th percentile)

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 42,460 followers.

RT @GlopesMd: The use of biosimilar medicines in oncology - position statement of the Brazilian Society of Clinical Oncology (SBOC) https:/…

RT @GlopesMd: @SBOC_Oncologia Position Statement on Biosimilars for Cancer Treatment in Brazil https://t.co/JIPS2OhnKz @ASCO @myesmo @uicc…

@SBOC_Oncologia Position Statement on Biosimilars for Cancer Treatment in Brazil https://t.co/JIPS2OhnKz @ASCO @myesmo @uicc @sylvestercancer

Congrats SBOC and all authors https://t.co/PBfMV3ehRm

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.